Catalog No.
Product Name
Application
Product Information
Citations
-
Drug Impurity
(1S,2R)-2-Fluorocyclopropan-1-amine hydrochloride is a chemical compound often encountered as a drug impurity. Its primary target is related to its role in the synthesis and analysis of various pharmaceutical formulations. This reagent is utilized in research applications focused on evaluating drug purity, stability, and potential biological impacts of impurities in pharmacological studies. -
Drug Intermediate
1-(3,3-Dimethyl-6-nitroindolin-1-yl)ethanone serves as a chemical intermediate in the synthesis of various active pharmaceutical compounds. Its unique structure and functional groups facilitate diverse chemical transformations, making it a valuable reagent in medicinal chemistry and drug development. This compound is primarily utilized in the design and preparation of bioactive molecules. -
Drug Impurity
Naproxen Impurity 4 is a characterized impurity associated with the nonsteroidal anti-inflammatory drug (NSAID) Naproxen. This compound is significant for quality control and analytical assessments in pharmaceutical research, providing insights into the purity and stability of Naproxen formulations. Its analysis can aid in understanding the compound's safety profile and potential effects on efficacy during drug development. -
Drug Impurity
Propofol Impurity 1 is a known impurity of the anesthetic agent Propofol, primarily used in the study of drug formulation purity and stability. Its characterization is essential for ensuring the quality of Propofol in pharmaceutical applications. Research involving this impurity can provide insights into the metabolization and potential effects associated with Propofol administration, contributing to safer therapeutic practices. -
Drug Intermediate
5-Bromotetralone, a synthetic intermediate known as 5-Bromo-3,4-dihydro-2H-naphthalen-1-one, serves a crucial role in pharmaceutical synthesis. This compound is utilized in the development of various bioactive molecules, facilitating research in medicinal chemistry and drug formulation. Its structural properties enable the creation of complex chemical entities, making it valuable in the production of therapeutic agents. -
Drug Intermediate
1-(4-Ethynyl-2-methoxyphenyl)-4-methyl-1H-Imidazole serves as a crucial drug intermediate in the synthesis of diverse active pharmaceutical compounds. Its unique structural properties enhance its utility in medicinal chemistry research and development. This reagent is integral for the formation of complex molecules, facilitating the exploration of new therapeutic agents within drug discovery processes. -
Drug Intermediate
1-(4-Bromophenyl)-1,3-dihydro-2H-imidazol-2-one serves as a versatile drug intermediate in organic synthesis, particularly in the development of bioactive compounds. This compound is utilized in the creation of various therapeutics, enhancing research in medicinal chemistry and pharmaceutical applications. Its imidazole framework offers potential for further modifications, enabling the exploration of diverse biological activities and therapeutic potentials. -
Drug Intermediate
4,5,6,7-Tetrafluoro-1-hydroxy-1,2-benziodoxole-3(1H)-one serves as a versatile drug intermediate, primarily utilized in the synthesis of diverse active pharmaceutical ingredients. Its unique structure and reactivity facilitate the development of complex compounds, making it valuable in medicinal chemistry and drug discovery research. This reagent is essential for researchers aiming to create novel therapeutic agents. -
Drug Intermediate
Methyl 1-benzyl-4-methylpyrrolidine-3-carboxylate is a chemical intermediate employed in the synthesis of diverse bioactive compounds. This reagent serves as a key building block in pharmaceutical research, facilitating the development of new therapeutic agents. Its structural properties make it suitable for various applications in medicinal chemistry and drug discovery. -
Drug Intermediate
2-(Hydroxymethyl)-pyrimidine serves as a vital synthetic intermediate in pharmaceutical research. Its chemical structure plays a crucial role in the development of various bioactive compounds. This reagent is applicable in the synthesis of pyrimidine derivatives, which are important in drug discovery and development processes. -
Drug Intermediate
(S)-2-Ethylpyrrolidine-2-carboxylic acid hydrochloride functions as a key drug intermediate in the synthesis of various bioactive compounds. Its structural properties facilitate the production of diverse pharmaceuticals, making it an important reagent in medicinal chemistry and drug discovery. This compound's applications extend to the development of novel therapeutic agents aimed at addressing a range of biological targets. -
Drug Intermediate
(S)-N-((S)-1-(((2R,4S)-1,2-Dihydroxy-2,6-dimethyl-3-oxoheptan-4-yl)amino)-1-oxo-3-phenylpropan-2-yl)-4-methyl-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamide serves as a critical drug intermediate in the synthesis of diverse pharmaceuticals. This compound is characterized by its complex structure, facilitating the production of bioactive molecules with potential therapeutic applications. Researchers employing this intermediate can explore various drug development pathways, particularly in the enhancement of pharmaceutical efficacy. -
Drug Intermediate
6-Amino-N-(2-(diethylamino)ethyl)quinoline-2-carboxamide serves as a crucial drug intermediate in the synthesis of various biologically active compounds. Its structure facilitates the formation of diverse medicinal agents, making it valuable in pharmaceutical development. This reagent is essential for researchers engaged in drug discovery and formulation. -
Drug Intermediate
2,4-Dimethyl-1H-imidazole-5-carbaldehyde acts as a versatile drug intermediate in the synthesis of diverse bioactive compounds. Its structural characteristics facilitate the development of pharmaceuticals and research molecules, making it valuable in medicinal chemistry. Researchers utilize this compound to explore new therapeutic agents and optimize chemical pathways in drug discovery. -
Drug Impurity
3,5-Dimethylbenzonitrile serves as a drug impurity often encountered during synthetic processes. This compound is important for quality control in pharmaceutical research, aiding in the identification and quantification of unintended byproducts. Its presence is relevant in the assessment of drug safety and efficacy, making it a valuable reagent in analytical chemistry and toxicology studies. -
Drug Intermediate
Ethyl 4-(2-chloropyridin-3-ylamino)piperidine-1-carboxylate is a key drug intermediate that facilitates the synthesis of a variety of bioactive compounds. Its unique structure enables it to engage in various chemical reactions, making it essential for medicinal chemistry applications. This reagent is pivotal in the development of novel pharmaceuticals, particularly those targeting central nervous system disorders and other therapeutic areas. -
Drug Impurity
Rivaroxaban impurity 43 is a specific impurity associated with the anticoagulant Rivaroxaban. This chemical reagent is primarily utilized in the characterization and analysis of Rivaroxaban formulations to ensure quality control and compliance with pharmaceutical standards. Its presence can impact the pharmacokinetics and safety profile of the drug, making it an essential component in drug formulation research and development. -
Drug Intermediate
2-(4-Aminophenoxy)-2-methylpropanoic acid is a drug intermediate utilized in the synthesis of diverse bioactive compounds. This chemical structure serves as a valuable building block in pharmaceutical research, facilitating the development of new therapeutic agents. Its reactivity and functional groups make it suitable for various chemical transformations and modifications in medicinal chemistry. -
Drug Intermediate
1-(4-Iodophenyl)-2-piperidinone functions as a valuable drug intermediate in chemical synthesis. It is commonly utilized in the production of various bioactive compounds, facilitating research in pharmacology and medicinal chemistry. This reagent is essential for developing new therapeutic agents and exploring structure-activity relationships in drug design. -
Drug Intermediate
2-Acetamidomalonate sodium serves as a versatile drug intermediate utilized in the synthesis of various bioactive compounds. Its chemical properties facilitate the incorporation of acetamido and malonate moieties, making it valuable in medicinal chemistry research. This reagent is essential for the development of pharmaceuticals and can be employed in projects focusing on drug discovery and optimization. -
Drug Intermediate
3-Chloro-2-isobutoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine is a versatile drug intermediate utilized in the synthesis of diverse active pharmaceutical ingredients. This compound serves as a key building block in chemical research, facilitating the development of novel therapeutic agents. Its unique chemical structure allows for multi-step syntheses, thus broadening its applicability in medicinal chemistry and drug discovery efforts. -
Drug Intermediate Control
6,7-Dihydroquinolin-8(5H)-one is a synthetic intermediate primarily utilized in pharmaceutical synthesis. This compound serves as a critical building block for the production of various bioactive molecules, facilitating the development of novel therapeutic agents. Its structural characteristics enable diverse chemical modifications, making it valuable in drug discovery and medicinal chemistry applications. -
Drug Intermediate
Ethyl 2-(4-hydroxyphenoxy)acetate serves as a valuable drug intermediate in the synthesis of diverse active pharmaceutical compounds. Its chemical structure facilitates the incorporation of the phenoxy group, enhancing the biological activity of derived products. This compound is pivotal in medicinal chemistry studies focused on developing novel therapeutic agents. -
Drug Intermediate
tert-Butyl 2-(1-(4-(ethoxycarbonyl)phenyl)ethylidene)hydrazinecarboxylate serves as a versatile drug intermediate in the synthesis of diverse active pharmaceutical ingredients. This compound facilitates the development of innovative therapeutic agents by acting as a key building block in chemical reactions. Its structural characteristics make it valuable for researchers focused on drug discovery and synthetic chemistry applications. -
Drug Impurity
Olmesartan impurity 13 is a specific impurity associated with the angiotensin II receptor blocker, Olmesartan. This compound is important for analytical and quality control applications in pharmaceutical research, particularly in ensuring the purity and safety of Olmesartan formulations. Its presence can impact the efficacy and safety profile of the drug, making it a relevant focus in pharmacological studies and drug development processes. -
Drug Intermediate
(S)-1-(4-(Trifluoromethoxy)phenyl)ethanamine acts as a crucial drug intermediate in the synthesis of diverse active pharmaceutical ingredients. Its unique trifluoromethoxy group enhances the pharmacological properties of the final products. This compound is instrumental in medicinal chemistry research, facilitating the development of new therapeutic agents. -
Drug Impurity
Amodiaquine impurity 1 is a drug impurity associated with Amodiaquine, a chloroquine derivative primarily utilized in antimalarial therapy. This impurity may impact the pharmacodynamics and stability of the parent compound, making it crucial for analytical and quality control studies in pharmaceutical research. Its characterization is essential for understanding drug formulation and ensuring compliance with regulatory standards. -
Drug Intermediate
Biphenyl-4-amidoxime is a synthetic intermediate with significant utility in pharmaceutical synthesis. This compound plays a crucial role in the development of various bioactive molecules and can facilitate the creation of potent drug candidates. Its application in the research and development of pharmaceuticals underscores its importance in medicinal chemistry. -
Drug Intermediate
Methyl 2-bromo-4-fluorobenzo[d]thiazole-6-carboxylate is a key drug intermediate known for its utility in the synthesis of diverse bioactive compounds. This compound serves as a versatile building block in medicinal chemistry, facilitating the development of novel therapeutic agents. Its unique structure contributes to various chemical modifications, making it valuable for research applications in drug discovery and development. -
Drug Intermediate
2-Methylindanone is a cyclic ketone compound that serves as a valuable substrate in the evaluation of palladium (Pd) and nickel (Ni) catalysts during asymmetric α-arylation reactions. Its utility as a drug intermediate enhances its relevance in synthetic organic chemistry. Researchers utilize 2-Methylindanone to explore novel synthetic pathways and develop pharmaceutical compounds. -
Drug Intermediate
Methyl 3-carbamoylbicyclo[1.1.1]pentane-1-carboxylate serves as a key drug intermediate, facilitating the synthesis of diverse bioactive compounds. Its unique bicyclic structure enhances its utility in the development of pharmaceutical agents. This reagent is vital for research focused on compound optimization and the exploration of novel therapeutic pathways. -
Drug Impurity
Nintedanib Impurity 6 is a drug impurity associated with the pharmaceutical compound Nintedanib, which acts as a multi-tyrosine kinase inhibitor. Its primary mechanism involves inhibiting kinases such as VEGFR, PDGFR, and FGFR, which are implicated in angiogenesis and tumor growth. This impurity may be used for analytical purposes in the development and quality control of Nintedanib, ensuring the integrity and safety of pharmaceutical formulations. Research applications include purity assessment and stability studies within pharmaceutical chemistry. -
Drug Intermediate
tert-Butyl (R)-3-(4-chlorophenyl)piperazine-1-carboxylate serves as an important drug intermediate utilized in the synthesis of diverse bioactive compounds. It plays a crucial role in the development of pharmaceuticals targeting various neurological and psychiatric disorders. This compound facilitates the exploration of new therapeutic options and enhances the efficiency of drug discovery processes. -
Drug Intermediate
(S)-4-Benzyl-3-(5-bromopentanoyl)oxazolidin-2-one serves as a versatile drug intermediate in the synthesis of active pharmaceutical ingredients. This compound features the oxazolidinone core, which is instrumental in the development of various therapeutic agents. Its unique structural attributes facilitate the creation of novel bioactive molecules for research applications in medicinal chemistry and pharmaceutical development. -
Drug Intermediate
(R)-1-(Benzo[d][1,3]dioxol-5-yl)butan-1-amine hydrochloride serves as a vital drug intermediate in the synthesis of diverse pharmacologically active compounds. Its structural framework supports the development of various chemical entities, which are essential for medicinal chemistry research. This compound facilitates the exploration of new therapeutic agents and is valuable for those engaged in organic synthesis and drug development studies. -
Drug Impurity
Theophylline impurity 9 is a known impurity identified in Theophylline. This compound serves as an important reference standard in the analysis and quality control of pharmaceutical formulations. Its characterization is crucial for ensuring compliance with regulatory standards and for understanding the pharmacological profile of Theophylline-containing products in therapeutic and research contexts. -
Drug Impurity
Indobufen impurity 4 is a minor impurity derived from Indobufen, a known antiplatelet agent. This compound is relevant for analytical research in pharmacokinetics and quality control, allowing for comprehensive impurity profiling in drug formulations. Its characterization is essential for ensuring the safety and efficacy of therapeutic agents in development. -
Drug Intermediate
2-Fluorofluoren-9-one serves as an important drug intermediate for the synthesis of a variety of bioactive compounds. This compound possesses key structural features that make it pivotal in the development of pharmacologically relevant molecules. Its application extends to medicinal chemistry, where it can facilitate the formation of complex chemical structures for drug discovery and development. -
Drug Intermediate
4-Amino-6-bromo-7H-pyrrolo[2,3-d]pyrimidine-5-carbonitrile is a chemical compound utilized as a drug intermediate in the synthesis of diverse bioactive molecules. With its unique structural features, it plays a critical role in the development of potential pharmaceuticals. This compound is significant in medicinal chemistry research, facilitating the creation of new therapeutic agents. -
Drug Impurity
N-Methyl-3-nitroaniline is a nitroaniline derivative primarily recognized for its role as a drug impurity. This compound is significant in chemical research for assessing purity levels and evaluating potential safety profiles of pharmaceutical formulations. N-Methyl-3-nitroaniline serves as a critical marker in stability studies and quality control processes within the drug development pipeline. -
Drug Impurity
Levetiracetam impurity 1 is a known impurity associated with the anticonvulsant agent Levetiracetam, primarily targeting the modulation of neurotransmitter release. This impurity can serve as a reference standard in analytical chemistry and pharmacokinetics studies, aiding in the evaluation of drug purity and stability. It is particularly useful in the development and quality control of pharmaceutical formulations containing Levetiracetam. -
Drug Impurity
Noradrenalone impurity 1 hydrochloride is a chemical compound characterized as an impurity of Noradrenalone. It serves as a reference standard for quality control in drug formulation and development, enabling researchers to investigate potential impurities in pharmaceutical products. This reagent is essential for ensuring the purity and safety of Noradrenalone in various biological and chemical research applications. -
Drug Intermediate
5-Methyl-8-hydroxycoumarin is a versatile drug intermediate, primarily utilized in the synthesis of a range of bioactive compounds. This molecule exhibits significant potential as a building block in organic chemistry, particularly in the development of pharmaceuticals and agrochemicals. Its unique structure and properties make it a valuable reagent in research and development settings focused on therapeutic applications. -
Drug Intermediate Control
D-2-Aminoglutarimide hydrochloride is a synthetic intermediate targeting the synthesis of hydantoins. This compound possesses anti-angiogenic properties and can induce differentiation in cancer cells, making it valuable for cancer research and drug development applications. Its role in the synthesis of bioactive molecules further supports studies in medicinal chemistry and potential therapeutic interventions. -
Drug Intermediate
2-(Benzyloxy)-4-fluorobenzaldehyde serves as an important drug intermediate in the synthesis of diverse active pharmaceutical compounds. This compound is characterized by its electrophilic aldehyde functionality, which facilitates further chemical transformations. It is widely used in organic synthesis and medicinal chemistry research to develop novel therapeutic agents. -
Drug Intermediate
5-Fluoro-2-methylpyridin-3-amine functions as a drug intermediate, facilitating the synthesis of diverse active pharmaceutical compounds. This pyridine derivative is significant in medicinal chemistry, aiding in the development of novel therapeutics. It is suitable for use in research applications focused on the design and optimization of drug candidates. -
Drug Intermediate
(2S,5S)-1-(((9H-Fluoren-9-yl)methoxy)carbonyl)-5-phenylpyrrolidine-2-carboxylic acid serves as an important drug intermediate in the synthesis of bioactive compounds. This compound is essential for the development of pharmaceuticals, providing a framework for various therapeutic agents. Its structural characteristics facilitate modifications that enhance biological activity, making it a valuable reagent in medicinal chemistry research. -
Drug Intermediate
3-Methoxyisoquinoline-1-carboxylic acid is a valuable drug intermediate primarily utilized in the synthesis of diverse active pharmaceutical ingredients. This compound serves as a critical building block in the development of therapeutic agents, facilitating the formation of various isoquinoline derivatives. Its applications extend to medicinal chemistry, where it contributes to the discovery and optimization of novel drug candidates. -
Drug Intermediate
2-((1s,4s)-4-Phenylcyclohexyl)acetic acid serves as a critical drug intermediate in the synthesis of diverse bioactive compounds. Its structural framework allows for the modification and development of novel pharmaceuticals, contributing to advancements in medicinal chemistry. This compound is of particular interest in the exploration of new therapeutic agents. -
Drug Impurity
Umeclidinium bromide impurity 8 is a known impurity of Umeclidinium bromide, which acts as a long-acting muscarinic antagonist (LAMA). This compound is primarily utilized for analytical purposes, especially in the characterization and quality control of pharmaceutical formulations containing Umeclidinium bromide. Its presence and quantification are crucial for ensuring compliance with regulatory standards in drug development and manufacturing.
